Sodium chloride
- Generic Name
- Sodium chloride
- Brand Names
- Amphenol-40, As 3, Bi-peglyte, Bicart, Bss, Bss Ophthalmic Solution, Cardioplegic, Citrasate, Clinimix E 2.75/5, Colyte, Corvatrol, Dextrose and Electrolyte No. 75, Dianeal, Dianeal Low Calcium 1.5, Dianeal Pd-2/1.5, Extraneal, Eye Stream, Gavilyte-C, Gavilyte-G, Gavilyte-H and Bisacodyl, Gavilyte-N, Golytely, H.E.L.P.bicel, Hemosate Ultra, Hespan, Hizentra, Hyperlyte, Intersol, Isolyte S, Isolyte S pH 7.4, Isoplate, Lactate 1-2-3, Lactated Ringers, Menopur, Moviprep, Muro 128, Naturalyte, Normosol-M, Normosol-R, Nulytely, Nxstage Pureflow, P-Care M, P-Care MG, P-care, P-care X, Peglyte, Phoxillum, Physiolyte, Physioneal 40, Physiosol, Plasma-lyte, Plasma-lyte 148, Plasma-lyte 148 In 5 % Dextrose, Plasma-lyte R, Plasmalyte A, Plegisol, Plenvu, Prismasol, Procalamine 3, Ringers, Sag-M, Sclerodex, Suflave, Tis-U-sol
- Drug Type
- Small Molecule
- Chemical Formula
- ClNa
- CAS Number
- 7647-14-5
- Unique Ingredient Identifier
- 451W47IQ8X
- Background
Sodium chloride, also known as salt, common salt, table salt or halite, is an ionic compound with the chemical formula NaCl, representing a 1:1 ratio of sodium and chloride ions. Sodium chloride is the primary salt in seawater and in the extracellular fluid of many multicellular organisms. It is listed on the World Health Organization Model List of Essential...
- Indication
This intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. Also, designed for use as a diluent and delivery system for intermittent intravenous administration of compatible drug additives.
- Associated Conditions
- Allergic Rhinitis (AR), Corneal Edema, Dehydration, Dehydration Hypertonic, Fluid Loss, Hemodilution, Hypokalemia, Hyponatremia, Hypotonic Dehydration, Hypovolaemia, Increase in Intracranial Pressure (ICP), Increased Intra Ocular Pressure (IOP), Inflammation of the Nasal Mucosa, Isotonic Dehydration, Metabolic Acidosis, Nasal Congestion, Nasal irritation, Oliguria caused by Acute Renal Failure (ARF), Potassium deficiency, Sinusitis, Skin Irritation, Sodium Depletion, Dryness of the nose, Hypochloremic state, Mild Metabolic acidosis, Mild, moderate Metabolic Acidosis
- Associated Therapies
- Electrolyte replacement, Fluid replacement therapy, Heart-Lung-Machine, Oral rehydration therapy, Parenteral Nutrition, Parenteral rehydration therapy, Peritoneal dialysis therapy, Plasma Volume Replacement, Regional Citrate Anticoagulation (RCA), Renal Replacement Therapies, Urine alkalinization therapy, Wound irrigation therapy, Ear wax removal, Fluid and electrolyte maintenance therapy, Increased renal excretion of toxic substances, Maintenance source of fluid and electrolytes, Parenteral drug administration, Reducing brain mass
Intravenous Iron to Treat Postoperative Anemia in Older Cardiac Surgery Patients
- Conditions
- Interventions
- First Posted Date
- 2021-06-04
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- dr. P. Noordzij
- Target Recruit Count
- 310
- Registration Number
- NCT04913649
- Locations
- 🇳🇱
Amphia Hospital, Breda, Netherlands
🇳🇱St Antonius Hospital, Nieuwegein, Netherlands
Bupivacaine in Tonsillectomy
- First Posted Date
- 2021-04-01
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- Nordlandssykehuset HF
- Target Recruit Count
- 84
- Registration Number
- NCT04825704
- Locations
- 🇳🇴
Nordland Hospital, Bodø, Norway
The Role of Lactate in Lipolysis and Catabolism in Humans
- Conditions
- Interventions
- First Posted Date
- 2021-01-15
- Last Posted Date
- 2022-01-24
- Lead Sponsor
- University of Aarhus
- Target Recruit Count
- 8
- Registration Number
- NCT04710875
- Locations
- 🇩🇰
Medical/Steno Aarhus research laboratory, Aarhus, Central Region Denmark, Denmark
🇩🇰Aarhus University Hospital, Aarhus N, Denmark
Resolving Inflammatory Storm in COVID-19 Patients by Omega-3 Polyunsaturated Fatty Acids -
- First Posted Date
- 2020-12-01
- Last Posted Date
- 2022-01-05
- Lead Sponsor
- Karolinska University Hospital
- Target Recruit Count
- 23
- Registration Number
- NCT04647604
- Locations
- 🇸🇪
Södersjukhuset, Stockholm, Sweden
🇸🇪Karolinska Universitetssjuhuset, Stockholm, Sweden
A Phase II Study of Subcutaneously Injected PD-L1 Antibody ASC22 in Chronic Hepatitis B Patients
- First Posted Date
- 2020-07-10
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- Ascletis Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 207
- Registration Number
- NCT04465890
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, China
Effect of Regulated Add -on Sodium Chloride Intake on Stabilization of Serum Lithium Concentration in Bipolar Disorder
- Conditions
- Interventions
- First Posted Date
- 2020-01-10
- Last Posted Date
- 2022-01-25
- Target Recruit Count
- 60
- Registration Number
- NCT04222816
- Locations
- 🇮🇳
Aiims Bhubaneswar, Khorda, Orissa, India
Multiple-dose Tolerability and Pharmacokinetic Studies of Benapenem in Clinical Healthy Subjects
- First Posted Date
- 2019-12-16
- Last Posted Date
- 2019-12-16
- Lead Sponsor
- Sihuan Pharmaceutical Holdings Group Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT04200261
- Locations
- 🇨🇳
Peking university first hospital, Peking, Beijing, China
Dexamethasone and Postoperative Bleeding Following Tonsillectomy in Children
- Conditions
- Interventions
- First Posted Date
- 2019-12-05
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- Walid HABRE
- Target Recruit Count
- 523
- Registration Number
- NCT04188431
- Locations
- 🇨🇦
Queen Elizabeth Hospital of Montreal, Mc Gill, Montreal, Quebec, Canada
🇨🇭geneva Children's Hospital, Geneva, Switzerland
Effect of Dexmedetomidine on Nol-Index Guided Remifentanil Analgesia
- Conditions
- Interventions
- First Posted Date
- 2019-04-11
- Last Posted Date
- 2020-04-03
- Lead Sponsor
- Erasme University Hospital
- Target Recruit Count
- 58
- Registration Number
- NCT03912740
- Locations
- 🇧🇪
Erasme University Hospital, Bruxelles, Belgium
Hemodynamics During Induction of General Anesthesia After Prophylactic Ephedrine, Phenylephrine or Norepinephrine.
- First Posted Date
- 2019-03-06
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- Helse Fonna
- Target Recruit Count
- 128
- Registration Number
- NCT03864094
- Locations
- 🇳🇴
Helse Fonna, Haugesund Sykehus, Haugesund, Norway
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.